Thomas Cluzeau

Academic History

Thomas Cluzeau, MD, PhD, is Professor of Hematology and Head of the Department of Hematology at Nice University Hospital, Nice, France. He also holds a faculty appointment as Professor at the Faculty of Medicine at Nice Sophia Antipolis University. Prof. Cluzeau completed his medical and research training across several esteemed institutions, including Nice Sophia Antipolis University, Nice University Hospital, Saint Louis Hospital, and Moffitt Cancer Center in Tampa, FL. He plays a key role in advancing hematologic research in France, actively contributing to multiple national cooperative research groups, including ALFA (Acute Leukemia French Association), GRAALL (Group for Research on Adult Acute Lymphoblastic Leukemia), and GFM (Groupe Francophone des Myélodysplasies).

Speaking on novel treatment strategies in AML

Prof. Cluzeau specializes in the diagnosis and management of hematologic malignancies, with particular focus on acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndromes (MDS). His research at the Mediterranean Center of Molecular Medicine in France is dedicated to translational and early-phase clinical trials, emphasizing genetic susceptibility and targeted treatments for AML. He leads both academic and industry-sponsored trials, aiming to bridge laboratory research with innovative clinical applications to improve patient outcomes.